The Role of Visceral Adipose Tissue in the Development of Hormonal and Metabolic Disorders in Patients with Diabetes Mellitus Type 2, Obesity and Arterial Hypertension
Journal Title: Міжнародний ендокринологічний журнал - Year 2014, Vol 4, Issue 60
Abstract
The article presents the results of adipokines (leptin and adiponectin) level study, as well as insulin resistance and secretory activity of the β-cells of the pancreas, depending on the amount of adipose tissue and its distribution type, studied using dual-energy X-ray absorptiometry, in 106 patients (50 men and 56 women aged 55.90 ± 2.15 years) with diabetes mellitus (DM, type 2, obesity and arterial hypertension, as compared with the control group (without DM, obesity, and hypertension). It has been shown that an excess amount of adipose tissue in patients with DM type 2 affects the development of hormone-metabolic disorders related to the features of adipokines production. It was found that overproduction of leptin by adipose tissue and decreased basal level of adiponectin in obesity create conditions to decrease the sensitivity of target cells to insulin-mediated glucose uptake, defatigation and subsequent depletion of the secretory function of β-cells of the pancreas, as well as to the maintenance of steady state of resistance to insulin and glucose homeostasis deviation towards hyperglycemic conditions prevail. Also there been shown physiologically determined sexual dimorphism of adipokines level conditioning higher tolerance of the female body to excess of adipose tissue mass. It was confirmed that the state of hyperleptinemia and hypoadiponectinemia underlie disorders of carbohydrate metabolism in patients with DM 2 with obesity and hypertension.
Authors and Affiliations
K. O. Zuyev
Keywords
Related Articles
- EP ID EP226934
- DOI -
- Views 63
- Downloads 0
Problem of Iodine Sufficiency in Republic of Belarus: Results of Introduction of Strategy to Control Iodine Deficiency
The results of introduction of strategy to control iodine deficiency in Republic of Belarus allowed the International Council for Control of Iodine Deficiency Disorders and Iodine Global Network to enter Belarus into the...
Monitoring the status of the blood circulation in the lower extremities in patients with diabetes mellitus
Background. Diabetes mellitus (DM) is a current medical and social problem. According to the data from International Diabetes Federation, 415 million people worldwide suffer from DM, and bу 2030, the number of patients i...
Sleep disorders in diabetes mellitus type 1 depending on glycemia daily monitoring and achievement of glycemia target levels
Background. Sleep disorders occur in more than 50 % of the population of developed countries. Changes both in the structure and duration of sleep impact the somatic state of patients. The role of sleep is significant for...
Guarem in the Clinical Practice in Patients with Type 2 Diabetes Mellitus
The paper presents the results of Guarem usage in 35 obese patients with impaired glucose metabolism. Guarem has a sufficient hypoglycemic effect and lipid-lowering action. The main benefit of this drug is a significant...
New Basal Insulin Toujeo Solostar: Increased Therapeutic Potential for the Control of Dysglycaemia in Diabetes Mellitus
This review examines the new formulation of insulin glargine (recombinant) in the form of injections 300 U/ml (Gla‑300, Toujeo®). Gla‑300 is a next generation basal insulin with a novel formulation of insulin glargin del...